Clinical Scorecard: Connection Between Hypothyroidism, Small Intestinal Bacterial Overgrowth Risk, and Alterations in the Duodenal Microbiome
At a Glance
Category
Detail
Condition
Hypothyroidism and Small Intestinal Bacterial Overgrowth (SIBO)
Key Mechanisms
Hypothyroidism-associated decreased gut motility may increase SIBO risk; alterations in small bowel microbiome including increased Gram-negative coliforms such as Klebsiella and Neisseria in hypothyroid patients
Target Population
Individuals with hypothyroidism including autoimmune thyroiditis
Care Setting
Clinical gastroenterology and endocrinology outpatient settings
Key Highlights
Higher prevalence of SIBO in hypothyroid patients (32.65%) compared to controls (15.17%)
10-year cumulative incidence of SIBO is increased in hypothyroidism (RR 2.20) and autoimmune thyroiditis (RR 2.40), mitigated by levothyroxine treatment
Distinct small bowel microbiome alterations in hypothyroid patients with SIBO, including presence of Klebsiella species and Neisseria genus
Guideline-Based Recommendations
Diagnosis
SIBO diagnosis via duodenal/jejunal aspirate with bacterial colony count ≥103 CFU/mL
Alternatively, breath testing with ≥20 ppm rise in exhaled hydrogen within 90 minutes after glucose or lactulose ingestion
Management
Levothyroxine treatment in hypothyroid patients may reduce risk of developing SIBO
Monitoring & Follow-up
Monitor gastrointestinal symptoms such as abdominal pain, bloating, and gas in hypothyroid patients
Consider microbiome assessment in research or specialized settings
Risks
Increased risk of SIBO in hypothyroid and autoimmune thyroiditis patients, potentially due to decreased gut motility and altered small bowel microbiome
Patient & Prescribing Data
Patients with hypothyroidism including autoimmune thyroiditis
Levothyroxine therapy is associated with reduced relative risk of developing SIBO in these patients
Clinical Best Practices
Consider evaluation for SIBO in hypothyroid patients presenting with gastrointestinal symptoms
Use appropriate diagnostic testing (aspirate culture or breath testing) to confirm SIBO
Optimize thyroid hormone replacement therapy to potentially mitigate SIBO risk
Recognize the role of specific Gram-negative bacteria in the small bowel microbiome alterations associated with hypothyroidism and SIBO
by Margaret Wei, Sepideh Mehravar, Gabriela Leite, Parnian Naji, Gillian M Barlow, Ava Hosseini, Mohamad Rashid, Maritza Sanchez, Cristina M Fajardo, Mark Pimentel, Ruchi Mathur
